MNKD FY 2012 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$869M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35,000-30.0% YoY

Gross Profit

$35,000100.0% margin

Operating Income

-$147M-419885.7% margin

Net Income

-$169M-483902.9% margin

EPS (Diluted)

$-4.68

Cash Flow

Operating Cash Flow

-$120M

Free Cash Flow

-$120M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$251M

Total Liabilities

$362M

Stockholders' Equity

-$111M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35,000	$50,000	-30.0%
Gross Profit	$35,000	$50,000	-30.0%
Operating Income	-$147M	-$141M	-4.6%
Net Income	-$169M	-$161M	-5.3%